Mesalamine 800 MG DR tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FVLZ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,704
Award facts
- Contract value 100% obligated
- $1,704.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,704.12 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180 count) with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical healthcare solutions provider, fulfills this order under its larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
The delivery order supports the Defense Logistics Agency's medical supply chain operations, which provision pharmaceuticals and medical supplies to military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. Mesalamine is a gastrointestinal anti-inflammatory medication used in the treatment of inflammatory bowel disease. This transaction exemplifies the routine pharmaceutical procurement activities conducted through AmerisourceBergen's comprehensive prime vendor contract, which enables flexible sourcing of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military readiness and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FVLZ5?
SPE2DB25FVLZ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FVLZ5 worth?
The government has obligated $1,704 on SPE2DB25FVLZ5.
Is contract SPE2DB25FVLZ5 an order under another contract?
Yes. SPE2DB25FVLZ5 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVLZ5 competed?
The extent of competition for SPE2DB25FVLZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award